Claim OwnershipCOVID-19 Science & Society
Subscribed: 8Played: 49
Subscribe
© 2024 COVID-19 Science & Society
Description
How will the world look like in 2022? Is SARS-CoV-2 here to stay with us? While some countries are opening towards normal life, albeit with cautious optimism, others are experiencing the hardest disease burden and public health crisis so far. Will vaccines be effective against new variants and how long the protection will last? What do we know so far about long COVID? Which patient populations could benefit most from emerging therapeutic options? Would there be resistance to new therapies? Subscribe to the COVID-19 Science & Society podcast to find out more on the most relevant and timely topics concerning the COVID pandemic.
10 Episodes
Reverse
Ravindra Gupta, MA, MPH, BMBCh, PhD, FRCP, FRCPath, FMedSci University of Cambridge, United Kingdom
Laura Waters, MD, FRCP Central & North West London NHS Foundation Trust, United Kingdom
Monica Gandhi, MD, MPH University of California San Francisco, United States
Jean Nachega MD, PhD, MPH, FRCP, FAAS University of Pittsburgh / Johns Hopkins University, United States Stellenbosch University, South Africa
Karine Lacombe, MD, PhD Hôpital Saint Antoine Paris, France
Michel Kazatchkine, MD The Global Health Center, Graduate Institute for International Affairs and Development References: The Independent Panel for Pandemic Preparedness & Response
Kathryn Stephenson, MD, MPH Beth Israel Deaconess Medical Center
Sanjay Bhagani, BSc, FRCP Consultant Physician in Infectious Diseases/HIV Medicine and General (internal) Medicine, Royal Free Hospital
Daniel Kuritzkes, MD Brigham and Women's Hospital; Harvard Medical School, United States Conflict of Interest Disclosure Receipt of grants/research support from Atea, Gilead, Merck, and ViiV Receipt of honoraria or consultation fees from Abpro, Atea, Decoy, Gilead, GlaxoSmithKline, Merck, Novartis, Rigel, ViiV
Long-term complications of COVID-19 Carlos del Rio, MD Emory School of Medicine & Grady Health System, United States Conflict of interest disclosure Carlos del Rio has received honoraria / consultation fees from Sanofi-Pasteur References US CDC - Post-COVID Conditions https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html#:~:text=Post%2DCOVID%20conditions%20are%20a,can%20have%20post%2DCOVID%20conditions. UK Office for National Statistics - Prevalence of Ongoing Symptoms Fol...
Comments
Download from Google Play
Download from App Store
United States